Insider filing · JAZZ
Samantha Pearce
EVP, Chief Commercial Officer
profile →
Jazz Pharmaceuticals plc
JAZZ · Healthcare · 46 filings in 24 months
ticker →
Samantha Pearce sold $1.6M of Jazz Pharmaceuticals (JAZZ)
Executed May 28, disclosed Jun 1, 4 days later.
Value, as filed
$1.6M
6,907 sh × $235.41
Executed
May 28
the trade date, as filed
Disclosed
Jun 1
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SPSamantha Pearce (EVP, Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $1.6M of JAZZ (6,907 sh × $235.41, as filed), executed May 28.
The name
JAZZHealthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→